Walleye Capital
INSP icon

Walleye Capital’s Inspire Medical Systems INSP Stock Holding History

Walleye Capital’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11M Sell
245,763
-112,726
-31% -$5.35M 0.04% 438
2026
Q1 		$18.5M Buy
358,489
+280,272
+358% +$19.6M 0.08% 222
2025
Q4 		$7.21M Sell
78,217
-50,396
-39% -$4.82M 0.02% 867
2025
Q3 		$9.54M Buy
128,613
+128,595
+714,417% +$13M 0.04% 569
2025
Q2 		$2.34K Sell
18
-1,653
-99% -$240K ﹤0.01% 4385
2025
Q1 		$266K Buy
1,671
+1,625
+3,533% +$294K ﹤0.01% 3038
2024
Q4 		$8.53K Sell
46
-1,090
-96% -$212K ﹤0.01% 4593
2024
Q3 		$240K Sell
1,136
-34,766
-97% -$6.04M ﹤0.01% 3865
2024
Q2 		$4.8M Buy
35,902
+35,277
+5,644% +$6.68M 0.01% 1322
2024
Q1 		$134K Buy
+625
New +$123K ﹤0.01% 4219
2023
Q4 		– Sell
-67,813
Closed -$11M – 5204
2023
Q3 		$13.5M Buy
+67,813
New +$17.1M 0.03% 423
2023
Q2 		– Sell
-9,919
Closed -$2.83M – 4571
2023
Q1 		$2.32M Sell
9,919
-12,922
-57% -$3.27M 0.03% 639
2022
Q4 		$5.75M Buy
22,841
+3,934
+21% +$839K 0.1% 237
2022
Q3 		$3.35M Buy
18,907
+11,012
+139% +$2.21M 0.06% 329
2022
Q2 		$1.44M Buy
7,895
+3,287
+71% +$655K 0.04% 474
2022
Q1 		$1.18M Buy
4,608
+3,141
+214% +$718K 0.03% 559
2021
Q4 		$337K Sell
1,467
-397
-21% -$96.9K 0.01% 1178
2021
Q3 		$434K Buy
+1,864
New +$389K 0.01% 843
2021
Q1 		– Sell
-6,332
Closed -$1.19M – 1251
2020
Q4 		$1.19M Buy
6,332
+3,764
+147% +$615K 0.08% 238
2020
Q3 		$331K Buy
+2,568
New +$283K 0.04% 481
2020
Q2 		– Sell
-2,560
Closed -$155K – 789
2020
Q1 		$155K Buy
2,560
+2,410
+1,607% +$178K 0.03% 496
2019
Q4 		$11K Buy
+150
New +$9.64K ﹤0.01% 1645

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Walleye Capital's INSP Position: Q2 2026 in Review

Walleye Capital reduced its Inspire Medical Systems (INSP) stake by 31% in Q2 2026, selling an estimated $5.35M and leaving 245,763 shares worth $11M. The position accounts for 0.04% of the portfolio, ranked #438.

Walleye Capital first reported a position in INSP in Q4 2019 and has held it in 22 quarters since. The position peaked at $18.5M in Q1 2026. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Walleye Capital held 245,763 shares of Inspire Medical Systems worth $11M as of Q2 2026.
  • Walleye Capital sold 112,726 Inspire Medical Systems shares in Q2 2026, an estimated $5.35M.
  • Inspire Medical Systems made up 0.04% of Walleye Capital's portfolio in Q2 2026, its #438 holding.
  • Walleye Capital first reported a position in Inspire Medical Systems in Q4 2019 and has held it in 22 quarters since.
  • Walleye Capital's Inspire Medical Systems position peaked at $18.5M in Q1 2026.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.